BRPI0513468A - método de produção de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodia-zepin-2 (1h)-ona - Google Patents

método de produção de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodia-zepin-2 (1h)-ona

Info

Publication number
BRPI0513468A
BRPI0513468A BRPI0513468-4A BRPI0513468A BRPI0513468A BR PI0513468 A BRPI0513468 A BR PI0513468A BR PI0513468 A BRPI0513468 A BR PI0513468A BR PI0513468 A BRPI0513468 A BR PI0513468A
Authority
BR
Brazil
Prior art keywords
piperidinyl
tetrahydro
benzodiazepin
production method
compound
Prior art date
Application number
BRPI0513468-4A
Other languages
English (en)
Inventor
Juergen Schnaubelt
Werner Rall
Rainer Soyka
Norbert Birk
Ludwig Gutschera
Heidelore Heimroth
Thomas Krueger
Armin Pr Ll
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0513468(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BRPI0513468A publication Critical patent/BRPI0513468A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

MéTODO DE PRODUçãO DE 3 - (4-PIPERIDINIL)-2,3,4,5 - TETRAHIDRO - 1,3 - BENZODIA - ZEPIN - 2 (1H) - ONA. A presente invenção refere-se a um método de produção de um composto de 3 - (4 - piperidinil) 2,3,4,5 - tetrahidro 1,3 - benzodiazepin - 2 (1H) - ona de fórmula (I), no qual o referido composto é um elemento estrutural dos antagonistas do CGRP que são particularmente adequados para o tratamento oral da enxaqueca.
BRPI0513468-4A 2004-07-23 2005-07-16 método de produção de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodia-zepin-2 (1h)-ona BRPI0513468A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04017424A EP1619187A1 (de) 2004-07-23 2004-07-23 Verfahren zur Herstellung von 3-(4-Piperidinyl)- 2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-on
PCT/EP2005/007778 WO2006010511A1 (de) 2004-07-23 2005-07-16 Verfahren zur herstellung 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1h)-on

Publications (1)

Publication Number Publication Date
BRPI0513468A true BRPI0513468A (pt) 2008-05-06

Family

ID=34925890

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513468-4A BRPI0513468A (pt) 2004-07-23 2005-07-16 método de produção de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodia-zepin-2 (1h)-ona

Country Status (19)

Country Link
US (1) US7141667B2 (pt)
EP (2) EP1619187A1 (pt)
JP (1) JP4516118B2 (pt)
KR (1) KR20070046881A (pt)
CN (2) CN102040590A (pt)
AR (1) AR050352A1 (pt)
AU (1) AU2005266579A1 (pt)
BR (1) BRPI0513468A (pt)
CA (1) CA2572811C (pt)
EA (1) EA011260B1 (pt)
EC (1) ECSP077190A (pt)
IL (1) IL180848A0 (pt)
MX (1) MX2007000906A (pt)
NO (1) NO20070366L (pt)
NZ (1) NZ553294A (pt)
TW (1) TW200613283A (pt)
UA (1) UA87507C2 (pt)
WO (1) WO2006010511A1 (pt)
ZA (1) ZA200609919B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101146799A (zh) 2005-03-23 2008-03-19 贝林格尔·英格海姆国际有限公司 Cgrp拮抗剂、其制备方法以及其作为药物的用途
US7473778B2 (en) 2005-12-24 2009-01-06 Boehringer Ingelheim International Gmbh 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one
DE102007038251A1 (de) 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren
EP2225223B1 (de) 2007-11-22 2017-01-11 Boehringer Ingelheim International GmbH Organische verbindungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474090A (en) * 1966-12-22 1969-10-21 American Cyanamid Co 3-aminoalkyl-1,3-benzodiazepin-2-ones
FR2518544A1 (fr) * 1981-12-22 1983-06-24 Lipha Benzodiazepines-1,3 thione-2, procede de preparation et medicament les contenant
DE19911039A1 (de) * 1999-03-12 2000-09-14 Boehringer Ingelheim Pharma Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2791021B1 (fr) * 1999-03-16 2001-05-11 France Design Arceau de protection pour vehicule decouvrable a toit repliable

Also Published As

Publication number Publication date
US7141667B2 (en) 2006-11-28
TW200613283A (en) 2006-05-01
AU2005266579A1 (en) 2006-02-02
ECSP077190A (es) 2007-03-29
MX2007000906A (es) 2007-04-13
CN102040590A (zh) 2011-05-04
JP4516118B2 (ja) 2010-08-04
EA011260B1 (ru) 2009-02-27
WO2006010511A8 (de) 2006-05-18
UA87507C2 (en) 2009-07-27
CN1989114A (zh) 2007-06-27
AR050352A1 (es) 2006-10-18
NO20070366L (no) 2007-02-06
WO2006010511A1 (de) 2006-02-02
EA200700041A1 (ru) 2007-08-31
NZ553294A (en) 2009-07-31
US20060019946A1 (en) 2006-01-26
JP2008507484A (ja) 2008-03-13
CA2572811C (en) 2012-09-11
EP1773789A1 (de) 2007-04-18
IL180848A0 (en) 2007-07-04
KR20070046881A (ko) 2007-05-03
ZA200609919B (en) 2008-07-30
EP1619187A1 (de) 2006-01-25
CA2572811A1 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
EA201200954A1 (ru) Способ получения полугидрата гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1н-3-бензазепина, фармацевтическая композиция на его основе и его применение
NO20092762L (no) 2-aza-bicyklo[3.1.0]heksanderivater
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
NO20084783L (no) Syntese av acylaminoalkenylenamider nyttige som substans P antagonister
GEP20105073B (en) Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
ECSP066376A (es) FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
BRPI0519597A2 (pt) derivados de (3r, 6r)-3-(2, 3-diidro-1h-inden-2-il)-2, 5-piperazinadiona 1, 6-substituÍda como antagonistas de receptores de oxitocina para o tratamento de parto prematuro, dismenorrÉia e endometriose
EA200870460A1 (ru) Производные циклогексилпиразол-лактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1
BRPI0408910A (pt) composto, composição farmacêutica e métodos para a profilaxia ou o tratamento de doenças ou condições e para a produção de uma composição farmacêutica
ATE482947T1 (de) Neues salz und polymorph des dpp-iv-hemmers
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
GB0621805D0 (en) Organic compounds
NO20091052L (no) Diaryleterderivater og anvendelser derav
BRPI0513468A (pt) método de produção de 3-(4-piperidinil)-2,3,4,5-tetrahidro-1,3-benzodia-zepin-2 (1h)-ona
ATE524451T1 (de) Substituierte n-benzo ädü isoxazol-3-yl-amin- derivative als inhibitoren von mglur5, serotonin- (5-ht) und noradrenalin rezeptoren und deren verwendung zur herstellung von arzneimitteln
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
MA33915B1 (fr) Nouveaux derives d' (heterocycle-piperidine condensee)-(piperazinyl)-1-alcanone ou d' (heterocycle-pyrrolidine condensee)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
BRPI0606783A2 (pt) derivados de imidazol
NO20092115L (no) Salt av 3-benzyl-2-metyl-2,3,3a,4,5,6,7,7a-oktahydrobenzo[d]isoksazol-4-on
EA201400570A1 (ru) СПОСОБ ПОЛУЧЕНИЯ БЕНЗОТИАЗЕПИНОВ ИЗ γ-АМИНОАЛКИЛБЕНЗОЛОВ
WO2006100026A8 (de) 2-oxo-1,2,4,5-tetrahydro-1,3-benzdiazepin-3-yl-piperidine als cgrp-antagonisten

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 7A ANUIDADE.